$COTY

Coty (COTY) Stock Revenue Holds Up While Margin Pressure Deepens

Coty (COTY) reported Q4 revenue of $1.27b but a net loss of $144.3m, with adjusted EBITDA falling sharply. Shares slipped 0.4% to $2.74. Bulls highlight free cash flow and debt reduction, while bears point to margin pressure and high leverage. Prestige brands remain a focus, but Consumer Beauty EBITDA declined 67% YoY.

Original reporting
Published Aug 22, 2026, 12:44 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 11:13 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Coty (COTY) Stock Revenue Holds Up While Margin Pressure Deepens — source image
Decision brief

The 30-second read

$COTYBearishLow
01

Why it matters

The earnings release highlights widening losses and margin compression, which may prompt short‑term price weakness.

02

Market read

Earnings miss for a large‑cap consumer beauty firm; relevant for sector investors and traders monitoring margin trends.

03

What to watch

Potential upside from upcoming prestige brand launches (Kylie, Burberry, Marc Jacobs) not yet reflected in the numbers.

Relevance 7/10Novelty 6/10Timing: post‑market earnings release

Background

Coty is a U.S.-listed beauty and cosmetics company (NASDAQ:COTY) that recently completed the transition of the Gucci brand.

Company-level read

Ticker impact

$COTYBearishMedium confidence
Context

Coty reported Q4 2026 results with revenue up 1.3% but a widened net loss of $144.3M and 190 bps margin compression.

Expected impact

Potential further downside pressure if margin issues persist; watch for support around $2.70.

Evidence & confidence

The disclosed loss and margin compression are new facts that could trigger sell‑offs, but cash flow remains positive, limiting the downside.

Market effects

Signals continued pressure on the consumer beauty sector, especially for companies with high leverage.

U.S. beauty stocks may see modest weakness as investors reassess margin outlooks.

Limited; primarily affects Coty and peers in the global cosmetics market.

Counterpoint

Free cash flow generation and debt reduction could support a rebound if margin trends improve.

Key entities

  • Coty Inc.

    U.S.-listed beauty products company.

Related articles

$COTYMed

Coty sees weak quarterly profit, withholds annual forecasts in 'transition year'

Coty reported Q4 revenue of $1.27B, beating estimates, but forecast Q1 EPS below expectations and withheld annual guidance. Shares fell 7% after hours. The company is undergoing a business overhaul, including a strategic review of its consumer beauty division, which may lead to brand sales. Coty appointed Soraya Benchikh as CFO. According to the company, Middle East conflict reduced quarterly sales by 1%.

$COTYMed

Coty Sees Weak Quarterly Profit, Withholds Annual Forecasts In 'Transition Year'

Coty reported Q4 revenue of $1.27B, beating estimates, but forecast Q1 EPS below expectations and withheld annual guidance. Shares fell 7% after hours. The company is undergoing a business overhaul, including a potential sale of brands like CoverGirl and Rimmel, and appointed a new CFO. Coty expects like-for-like revenue to decline in Q1, with Middle East conflict and oil prices impacting results.

$WMTHighAI 8/10

Wall Street sinks as bond yields rise, Walmart results disappoint

U.S. equity indexes fell as Treasury yields rose, hurting risk appetite. Walmart shares dropped 9.2% after missing sales expectations, dragging down consumer sectors. Oil prices rose, increasing inflation concerns. Other retailers like Costco and Dollar Tree also declined. Bond yields advanced despite Treasury repurchase plans. The Dow, S&P 500, and Nasdaq all fell, with consumer staples and healthcare among the worst-performing sectors. Cryptocurrency-related stocks rallied over 7%.

$COTYMedAI 8/10

Coty widens losses ahead of a “transition” year without Gucci

Coty reported a wider net loss of $618M for fiscal 2025/26, up from $381M a year earlier, with sales falling 5% to $5.8B. Q4 sales rose 1%, showing early signs of stabilization. The company plans to use proceeds from the Gucci Beauty license transfer to Kering to reduce debt and invest in its core business. Coty forecasts a 'transition' year in fiscal 2027 as it refocuses on fragrances and beauty products.

$COTYMedAI 8/10

Coty Targets Portfolio Growth by 2028, Focuses on Innovation and Brand Investment Amid Gucci License Transition

Coty aims to return its portfolio, excluding Gucci, to growth by 2028. The company will focus on innovation and brand investment, particularly for Hugo Boss and Marc Jacobs. Coty will receive $400 million from L’Oréal for the early transfer of the Gucci Beauty license. The company plans to complete a review of its consumer beauty business by the end of 2026.